北京博士理医药技术有限公司

Beijing Bossly Pharmaceutical Technology Co., Ltd. is a specialized biotechnology company and CRO focused on the development of inhalation drug delivery systems for respiratory diseases. Based in Beijing's Daxing Bio-Medicine Industry Park, the company excels in the formulation and device integration of dry powder inhalers (DPI), metered-dose inhalers (MDI), and nebulizers. Their portfolio includes high-barrier generic drugs and improved new drugs targeting asthma and chronic obstructive pulmonary disease (COPD). Bossly operates a comprehensive technology platform that integrates formulation science with proprietary inhalation device design. The company provides end-to-end services from particle engineering and aerodynamic testing to clinical development and manufacturing support. Their expertise in pulmonary drug delivery ensures high lung deposition and therapeutic efficacy for complex inhaled medications.